Tharimmune Non-Current Deferred Revenue (Quarterly) Trends

Tharimmune, Inc. (THAR)

3.075 +0.18 (+6.40%) USD | NASDAQ | Jan 14, 16:00

3.05 -0.02 (-0.81%) After-Hours: 18:18

View Non-Current Deferred Revenue (Quarterly) for THAR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Phio Pharmaceuticals Corp.	--
ETHZilla Corp.	--
Flora Growth Corp.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--